Skip to Content

B 251 (Phenazopyridine Plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg)

Pill with imprint B 251 is Brown, Elliptical / Oval and has been identified as Phenazopyridine Plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Butabarbital/hyoscyamine/phenazopyridine is used in the treatment of dysuria and belongs to the drug class urinary antispasmodics. There is positive evidence of human fetal risk during pregnancy. Butabarbital/hyoscyamine/phenazopyridine butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B 251

Phenazopyridine plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg B 251

Phenazopyridine Plus

Imprint
B 251
Strength
butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg
Color
Brown
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC)
51991-0251

Get help with Imprint Code FAQs.

Related Images for "B 251"

More about butabarbital / hyoscyamine / phenazopyridine

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.